Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly D Getz

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Pediatric Blood & Cancer|October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Journal of the American Heart Association|January 22, 2020
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac DysfunctionBiniyam G Demissei, Rebecca A Hubbard, Liyong Zhang, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
JAMA Network Open|January 15, 2026
Air Pollution and Cardiac Remodeling and Function in Patients With Breast CancerWonyoung Jung, Kyunga Ko, Amanda M Smith, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Pediatric Blood & Cancer|October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Journal of the American Heart Association|January 22, 2020
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac DysfunctionBiniyam G Demissei, Rebecca A Hubbard, Liyong Zhang, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
JAMA Network Open|January 15, 2026
Air Pollution and Cardiac Remodeling and Function in Patients With Breast CancerWonyoung Jung, Kyunga Ko, Amanda M Smith, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Pageof 8